Anthera Pharmaceuticals Inc. (ANTH) has reached the enrollment target of 400 patients in its phase III clinical trial evaluating Blisibimod for the treatment of lupus.
Forex – financial instrument.Forex news
Anthera Pharmaceuticals Inc. (ANTH) has reached the enrollment target of 400 patients in its phase III clinical trial evaluating Blisibimod for the treatment of lupus.